BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24709436)

  • 1. Prevalence and clinicopathologic correlates of O⁶-methylguanine-DNA methyltransferase methylation status in patients with triple-negative breast cancer treated preoperatively by alkylating drugs.
    Fumagalli C; Della Pasqua S; Bagnardi V; Cardillo A; Sporchia A; Colleoni M; Viale G; Barberis M; Pruneri G
    Clin Breast Cancer; 2014 Aug; 14(4):285-90. PubMed ID: 24709436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
    Fumagalli C; Pruneri G; Possanzini P; Manzotti M; Barile M; Feroce I; Colleoni M; Bonanni B; Maisonneuve P; Radice P; Viale G; Barberis M
    Breast Cancer Res Treat; 2012 Jul; 134(1):131-7. PubMed ID: 22228432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response.
    Switzeny OJ; Christmann M; Renovanz M; Giese A; Sommer C; Kaina B
    Clin Epigenetics; 2016; 8():49. PubMed ID: 27158275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
    Jank P; Gehlhaar C; Bianca L; Caterina F; Andreas S; Karn T; Marmé F; Sinn HP; van Mackelenbergh M; Sinn B; Zahm DM; Ingold-Heppner B; Schem C; Stickeler E; Fasching PA; Nekljudova V; Taube ET; Heppner F; Müller V; Denkert C; Loibl S
    PLoS One; 2020; 15(8):e0238021. PubMed ID: 32841306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing.
    Xie H; Tubbs R; Yang B
    Int J Clin Exp Pathol; 2015; 8(1):636-42. PubMed ID: 25755756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status.
    Kakkar A; Kumar A; Jha P; Goyal N; Mallick S; Sharma MC; Suri A; Singh M; Kale SS; Julka PK; Sarkar C; Suri V
    Neuropathology; 2014 Aug; 34(4):333-42. PubMed ID: 24521400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
    Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
    Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
    Wick W; Meisner C; Hentschel B; Platten M; Schilling A; Wiestler B; Sabel MC; Koeppen S; Ketter R; Weiler M; Tabatabai G; von Deimling A; Gramatzki D; Westphal M; Schackert G; Loeffler M; Simon M; Reifenberger G; Weller M
    Neurology; 2013 Oct; 81(17):1515-22. PubMed ID: 24068788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short article: Evaluation of O6-methylguanine-DNA methyltransferase as a predicting factor of response to temozolomide-based chemotherapy in well-differentiated metastatic pancreatic neuroendocrine tumors.
    Girot P; Dumars C; Mosnier JF; Muzellec L; Senellart H; Foubert F; Caroli-Bosc FX; Cauchin E; Regenet N; Matysiak-Budnik T; Touchefeu Y
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):826-830. PubMed ID: 28328619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.
    Reifenberger G; Hentschel B; Felsberg J; Schackert G; Simon M; Schnell O; Westphal M; Wick W; Pietsch T; Loeffler M; Weller M;
    Int J Cancer; 2012 Sep; 131(6):1342-50. PubMed ID: 22139906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the histone H3 lysine 4 methyltransferase MLL4 and the histone H3 lysine 27 demethylase UTX prolonging the overall survival of patients with glioblastoma and a methylated MGMT promoter.
    Kim J; Lee SH; Jang JH; Kim MS; Lee EH; Kim YZ
    J Neurosurg; 2017 May; 126(5):1461-1471. PubMed ID: 27367247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of MGMT promoter methylation in glioblastoma using pyrosequencing.
    Xie H; Tubbs R; Yang B
    Int J Clin Exp Pathol; 2015; 8(2):1790-6. PubMed ID: 25973069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
    Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications.
    Kang SH; Park KJ; Kim CY; Yu MO; Park CK; Park SH; Chung YG
    J Neurooncol; 2011 Feb; 101(3):477-86. PubMed ID: 20556478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India.
    Nehru GA; Pai R; Samuel P; Chacko AG; Chacko G
    Neurol India; 2012; 60(5):481-6. PubMed ID: 23135024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer.
    Onerci Celebi O; Tezel GG; Hosal AS; Cengiz M; Gullu IH; Hayran M
    Pathol Res Pract; 2016 May; 212(5):456-62. PubMed ID: 27067808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
    Amatu A; Sartore-Bianchi A; Moutinho C; Belotti A; Bencardino K; Chirico G; Cassingena A; Rusconi F; Esposito A; Nichelatti M; Esteller M; Siena S
    Clin Cancer Res; 2013 Apr; 19(8):2265-72. PubMed ID: 23422094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP.
    Kristensen LS; Nielsen HM; Hager H; Hansen LL
    Lung Cancer; 2011 Feb; 71(2):130-6. PubMed ID: 20627446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.